vs
Side-by-side financial comparison of Ovid Therapeutics Inc. (OVID) and Serve Robotics Inc. (SERV). Click either name above to swap in a different company.
Serve Robotics Inc. is the larger business by last-quarter revenue ($881.5K vs $718.0K, roughly 1.2× Ovid Therapeutics Inc.). On growth, Ovid Therapeutics Inc. posted the faster year-over-year revenue change (844.7% vs 400.1%). Over the past eight quarters, Ovid Therapeutics Inc.'s revenue compounded faster (120.3% CAGR vs -3.5%).
Ecovacs Robotics is a Chinese technology company. It is best known for developing in-home robotic appliances. The company was founded in 1998 by Qian Dongqi and is headquartered in Suzhou, China. According to Global Asia, Ecovacs Robotics had more than 60% of the Chinese market for robots by 2013. In 2023, Nikkei Asia had reported that the market capitalisation of Ecovacs Robotics has grown to near $6.38 billion, which is "roughly 5 times" that of the market capitalisation of rivalling US bas...
OVID vs SERV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $718.0K | $881.5K |
| Net Profit | — | $-34.3M |
| Gross Margin | — | -757.3% |
| Operating Margin | — | -4572.1% |
| Net Margin | — | -3888.1% |
| Revenue YoY | 844.7% | 400.1% |
| Net Profit YoY | 204.4% | -161.3% |
| EPS (diluted) | — | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $718.0K | $881.5K | ||
| Q3 25 | $132.0K | $687.0K | ||
| Q2 25 | $6.3M | $642.0K | ||
| Q1 25 | $130.0K | $440.5K | ||
| Q4 24 | $76.0K | $176.3K | ||
| Q3 24 | $173.0K | $222.0K | ||
| Q2 24 | $169.0K | $468.0K | ||
| Q1 24 | $148.0K | $946.7K |
| Q4 25 | — | $-34.3M | ||
| Q3 25 | $-12.2M | $-33.0M | ||
| Q2 25 | $-4.7M | $-20.9M | ||
| Q1 25 | $-10.2M | $-13.2M | ||
| Q4 24 | — | $-13.1M | ||
| Q3 24 | $-14.0M | $-8.0M | ||
| Q2 24 | $8.5M | $-9.0M | ||
| Q1 24 | $-11.7M | $-9.0M |
| Q4 25 | — | -757.3% | ||
| Q3 25 | — | -637.4% | ||
| Q2 25 | — | -445.3% | ||
| Q1 25 | — | -333.4% | ||
| Q4 24 | — | -371.7% | ||
| Q3 24 | — | -70.3% | ||
| Q2 24 | — | 30.3% | ||
| Q1 24 | — | 62.8% |
| Q4 25 | — | -4572.1% | ||
| Q3 25 | -9487.1% | -5067.8% | ||
| Q2 25 | -80.9% | -3527.1% | ||
| Q1 25 | -9653.8% | -3406.6% | ||
| Q4 24 | — | -7701.3% | ||
| Q3 24 | -7645.1% | -3804.1% | ||
| Q2 24 | -12140.2% | -1828.2% | ||
| Q1 24 | -11768.2% | -814.6% |
| Q4 25 | — | -3888.1% | ||
| Q3 25 | -9210.6% | -4806.4% | ||
| Q2 25 | -74.7% | -3247.7% | ||
| Q1 25 | -7873.1% | -3000.5% | ||
| Q4 24 | — | -7441.8% | ||
| Q3 24 | -8096.0% | -3601.8% | ||
| Q2 24 | 5042.0% | -1931.2% | ||
| Q1 24 | -7901.4% | -954.7% |
| Q4 25 | — | $-0.50 | ||
| Q3 25 | — | $-0.54 | ||
| Q2 25 | — | $-0.36 | ||
| Q1 25 | — | $-0.23 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | $-0.20 | $-0.20 | ||
| Q2 24 | $0.12 | $-0.27 | ||
| Q1 24 | $-0.17 | $-0.37 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.2M | $106.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $130.7M | $350.7M |
| Total Assets | $150.9M | $367.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.2M | $106.2M | ||
| Q3 25 | $20.6M | $116.8M | ||
| Q2 25 | $28.4M | $116.7M | ||
| Q1 25 | $21.1M | $197.8M | ||
| Q4 24 | $26.3M | $123.3M | ||
| Q3 24 | $15.0M | $50.9M | ||
| Q2 24 | $29.7M | $28.8M | ||
| Q1 24 | $30.8M | — |
| Q4 25 | $130.7M | $350.7M | ||
| Q3 25 | $44.7M | $283.9M | ||
| Q2 25 | $55.8M | $207.2M | ||
| Q1 25 | $59.3M | $210.2M | ||
| Q4 24 | $68.2M | $131.7M | ||
| Q3 24 | $76.3M | $56.2M | ||
| Q2 24 | $88.9M | $28.5M | ||
| Q1 24 | $78.3M | $-8.8M |
| Q4 25 | $150.9M | $367.8M | ||
| Q3 25 | $63.8M | $299.1M | ||
| Q2 25 | $77.4M | $214.3M | ||
| Q1 25 | $81.7M | $216.6M | ||
| Q4 24 | $92.2M | $139.6M | ||
| Q3 24 | $102.7M | $61.5M | ||
| Q2 24 | $118.1M | $32.8M | ||
| Q1 24 | $131.6M | $4.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-38.3M | $-29.6M |
| Free Cash FlowOCF − Capex | — | $-46.1M |
| FCF MarginFCF / Revenue | — | -5234.4% |
| Capex IntensityCapex / Revenue | 0.0% | 1872.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-117.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-38.3M | $-29.6M | ||
| Q3 25 | $-12.9M | $-25.2M | ||
| Q2 25 | $-4.8M | $-16.0M | ||
| Q1 25 | $-10.3M | $-9.5M | ||
| Q4 24 | $-56.0M | $-6.3M | ||
| Q3 24 | $-15.0M | $-5.5M | ||
| Q2 24 | $-14.3M | $-5.7M | ||
| Q1 24 | $-16.7M | $-4.1M |
| Q4 25 | — | $-46.1M | ||
| Q3 25 | — | $-36.5M | ||
| Q2 25 | — | $-22.0M | ||
| Q1 25 | — | $-12.9M | ||
| Q4 24 | $-56.0M | $-11.1M | ||
| Q3 24 | $-15.0M | $-10.1M | ||
| Q2 24 | $-14.3M | $-6.5M | ||
| Q1 24 | $-16.7M | $-4.1M |
| Q4 25 | — | -5234.4% | ||
| Q3 25 | — | -5314.1% | ||
| Q2 25 | — | -3426.8% | ||
| Q1 25 | — | -2934.1% | ||
| Q4 24 | -73719.7% | -6307.8% | ||
| Q3 24 | -8676.9% | -4529.7% | ||
| Q2 24 | -8455.0% | -1396.6% | ||
| Q1 24 | -11287.2% | -431.1% |
| Q4 25 | 0.0% | 1872.1% | ||
| Q3 25 | 0.0% | 1649.6% | ||
| Q2 25 | 0.0% | 940.4% | ||
| Q1 25 | 0.0% | 785.7% | ||
| Q4 24 | 93.4% | 2755.1% | ||
| Q3 24 | 2.3% | 2070.7% | ||
| Q2 24 | 20.1% | 169.8% | ||
| Q1 24 | 12.8% | 0.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.67× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
